Ikena Oncology, Inc. Contracts & Agreements
19 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (4)
- Intellectual Property (2)
- Mergers & Acquisitions (3)
- Real Estate (1)
- Uncategorized (1)
- Contingent Value Rights Agreement, dated August 4, 2023, by and between Ikena Oncology, Inc. and Computershare Trust Company N.A, as rights agent (Filed With SEC on August 7, 2023)
- Agreement and Plan of Merger, dated August 4, 2023, by and among Ikena Oncology, Inc., Portsmouth Merger Sub I, Inc., Portsmouth Merger Sub II, LLC, Pionyr Immunotherapeutics,... (Filed With SEC on August 7, 2023)
- Underwriting Agreement, dated May 15, 2023, by and between Ikena Oncology, Inc. and Cowen and Company, LLC, as representative of the several underwriters named therein (Filed With SEC on May 15, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 17, 2022)
- Specimen Common Stock Certificate (Filed With SEC on March 22, 2021)
- Form of Amended and Restated Employment Agreement (Filed With SEC on March 22, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 22, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on March 22, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on March 22, 2021)
- 2021 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on March 22, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 22, 2021)
- Agreement and Plan of Merger by and among the Registrant, Arrys Merger Sub, Inc., Arrys Therapeutics, Inc. and OrbiMed Private Investments VI, LP, as stockholder representative,... (Filed With SEC on March 5, 2021)
- Lease Agreement between the Registrant and OPG MP Parcel Owner (DE) LLC, dated July 31, 2020 (Filed With SEC on March 5, 2021)
- Patent License Agreement by and between the Registrant and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System, dated March 29,... (Filed With SEC on March 5, 2021)
- Master Collaboration Agreement by and between the Registrant and Celgene Corporation (now Bristol-Myers Squibb), dated January 14, 2019 (Filed With SEC on March 5, 2021)
- License Agreement by and between the Registrant and AskAt, Inc., dated December 14, 2017, as amended on December 18, 2018 (Filed With SEC on March 5, 2021)
- 2016 Stock Incentive Plan, and form of award agreements thereunder (Filed With SEC on March 5, 2021)
- Fourth Amended and Restated Investors Rights Agreement (Filed With SEC on March 5, 2021)
- Agreement and Plan of Merger by and among the Registrant, AMI Merger Sub, Inc., Amplify Medicines, Inc. and Atlas Venture Fund XI, L.P. as stockholder representative, dated... (Filed With SEC on March 5, 2021)
